Harness Industry Change

Whether the threat of new or powerful competitors, the changing role of physicians as decision-makers, or the shift from episodic to chronic care and risk-sharing, creating sustainable and profitable growth is more challenging than ever. In Global Strategies for Medical Device Growth, participants examine industry disruption from a range of unique perspectives, learning practical and timely skills and methodologies to accelerate the organization’s growth and ensure its success across the globe.

With Duke University’s decades of medical device experience, our Health Sector Management program – the largest health industry program among top US business schools - and Duke Margolis Center for Health Care Policy, we are uniquely positioned to offer new perspectives and industry research findings across the domain. Participants gain insights through faculty-led case discussions, exploring the different perspectives of competitive and complementary industry players. Through interactive exercises they draw relevant insights from academic concepts, while team and individual assignments help them identify strategies and action plans to apply at work immediately.

Who Should Attend?

Business leaders or medical device professionals who are responsible for driving sustainable company growth in a dynamic, constantly changing industry environment.

Program Availability

This program is available upon request. Please contact us if you're interested in tailoring this program for your organization.

More About this Program

The Global Strategies for Medical Device Growth curriculum will provide instructional review of:

  •         Strategic options for corporations to drive sustainable, global growth
  •         Medical device industry megatrends and their implications for future competitiveness and strategy
  •         Determining which disruptive forces could succeed in the constrained health care space with government regulation and reimbursement, and how to leverage these forces to your advantage
  •         Lessons learned from disruption in the generic pharmaceutical industry and what implications that might have for medical devices
  •         How to address the value segment threat and which strategies to compete with this threat will produce the best outcomes
  •         How large companies can maintain an entrepreneurial spirit among their leaders
  •         Lessons learned from nascent start-up companies
  •         Practical application of theory to current issues facing your business

Three highly-ranked faculty members with practical, real-world medical device experience lead participants through case studies, team activities, and interactive exercises. These sessions translate academic theory into viable plans that a team can put into action back in the office. The course culminates in a final session that focuses on each participant committing to one strategic change that will translate into a meaningful business result for the firm.

Contact Details

Duke University's Fuqua School of Business
100 Fuqua Drive
Durham, NC 27708-0120 USA
Tel +1.919.660.8011
Toll Free +1.800.372.3932

Office Hours
Monday - Friday
8:30 a.m. - 5:00 p.m.

Sample Schedule

Day 1

Arrival and Registration
8:00 AM - 1:00 PM

Class Topics:
1:00 PM - 5:00 PM

  • Corporate Strategies for Driving Global Growth
  • Medical Device Megatrends--Implications for Future Competitiveness
  • Case:  Omar Ishrak: Building Medtronic Globally

Hotel Check-in
5:00 PM - 6:00 PM

6:00 PM - 7:30 PM

Team Homework
7:30 PM - 9:30 PM


Day 2

6:45 AM - 8:00 AM

Class Topics:
8:00 AM - 12:00 Noon

  • Teva Pharmaceuticals, Ltd. Case Discussion
  • Value Segment Threat and Competitive Strategies
  • Disruption in Health Care

12:00 Noon - 1:00 PM

Class Topics:
1:00 PM - 4:00 PM

  • DaVita Case Discussion
  • Winning Strategies: Entrepreneurial Thinking in Large Companies

Duke Campus/Cameron Indoor Stadium Tour
4:00 PM - 5:00 PM

6:00 PM - 7:30 PM

Individual Homework
7:30 PM - 9:30 PM

Day 3

6:45 AM - 8:00 AM

Class Topics:
8:00 AM - 11:30 AM

  • Innovation: Lessons Learned from Start-up Companies
  • Practical Application of Theory to Customer's Current Business & Core Values

Check out of hotel rooms
11:30 AM - 12:00 Noon

12:00 Noon - 1:00 PM



Professor David Ridley

David Ridley

David Ridley is a professor of business and economics and the faculty director of the Health Sector Management program at Duke University’s Fuqua School of Business. Professor Ridley’s research examines innovation and pricing, and led to his authoring a paper proposing the Priority Review Voucher program encouraging development of medications for neglected diseases that became law in 2007. He has consulted for life sciences companies including Amgen, Eli Lily, Genentech, GlaxoSmithKline, Novartis, and Pfizer.

Professor Aaron Chatterji

Aaron Chatterji

Aaron Chatterji, Ph.D. is an Associate Professor at Duke University’s Fuqua School of Business. He previously served as a Senior Economist at the White House Council of Economic Advisors (CEA) where he worked on a wide range of policies relating to entrepreneurship, innovation, infrastructure and economic growth. His research has been published in leading academic journals and been cited by CNN and The Economist. He has authored several op-ed pieces, including in the New York Times and the Wall Street Journal, appeared on national TV and radio, and was recently profiled in The Financial Times and Fortune.

Greg Davis

J. Greg Davis

Mr. Davis is a seasoned medical device executive with broad global and functional experience in finance, manufacturing, sales and general management. He is currently the Founder & CEO of The MedCelerate Consulting Group (www.medcelerate.com), whose mission is to enable medical device companies to grow and succeed commercially at a faster velocity. The practice focuses on clearing early product development and clinical milestones through full manufacturing and commercial ramp-up activities.